| | | | | | | | | | |
|
| |
|
| Dockets
Entered On January 27, 2004
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 2003D-0570
|
| Draft on the Clinical Evaluation of Weight-Control Drugs
|
|
|
|
|
| 2003E-0411
|
| Patent Term Restoration Application for Facitive (gemifloxacin mesylate), U.S. Patent No. 5,633, 262
|
|
|
|
|
| 2003E-0448
|
| Patent Extension for FACTIVE, gemifloxacin mesylate, #5,776,944
|
|
|
|
|
| 2003N-0327
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Guidance for Industry on How to Use E-Mail to Submit a Request For a Meeting or Teleconference to the Office of New Anim
|
|
|
|
|
|
|
|
|
| 2003N-0329
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Guidance for Industry on How to Use E-Mail to Submit Information to the Center for Veterinary Medicine
|
|
|
|
|
| 2003N-0404
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Human Tissue Intended for Transplantation
|
|
|
|
|
| 2004E-0039
|
| Patent Extension for CRESTOR (rosuvastatin), U.S. Patent No. RE37,314
|
|
|
|
|
| 2004E-0040
|
| Patent Extension for CYDECTIN, U.S. Patent No. 4,916,154
|
|
|
|
|
| 2004M-0022
|
| P010059 - Morcher Capsular Tension Ring, Types 14, 14A and 14C, Approved 10/23/03
|
|
|
|
|
| 2004M-0024
|
| P970020/S040 - ACS MULTI-LINK RX DUET, ACS MULTI-LINK OTW DUET, ACS MULTI-LINK RX TRISTAR, ACS MULTI-LINK OTW TRISTAR, ACS MULTI-LINK RX ULTRA, ACS MULTI-LINK OTW ULTRA, ACS MULTI-LINK RX TETRA, ACS M
|
|
|
|
|
|
|
|
|
| 2004M-0031
|
| PMA P020031, Microsulis Microwave Endometrial Ablation (MEA) System
|
|
| |
|
| 2003D-0570
|
| Draft on the Clinical Evaluation of Weight-Control Drugs
|
|
|
|
|
| GDL
1
|
| Guidance
|
| Vol #:
|
| 1
|
|
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003E-0411
|
| Patent Term Restoration Application for Facitive (gemifloxacin mesylate), U.S. Patent No. 5,633, 262
|
|
|
|
|
| LET
3
|
| U.S. Patent & Trademark Office
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003E-0448
|
| Patent Extension for FACTIVE, gemifloxacin mesylate, #5,776,944
|
|
|
|
|
| LET
3
|
| U.S. Patent & Trademark Office
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0327
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Guidance for Industry on How to Use E-Mail to Submit a Request For a Meeting or Teleconference to the Office of New Anim
|
|
|
|
|
|
|
|
|
| N
2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0329
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Guidance for Industry on How to Use E-Mail to Submit Information to the Center for Veterinary Medicine
|
|
|
|
|
|
|
|
|
| N
2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0404
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Human Tissue Intended for Transplantation
|
|
|
|
|
| N
2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004E-0039
|
| Patent Extension for CRESTOR (rosuvastatin), U.S. Patent No. RE37,314
|
|
|
|
|
| APP 1
|
| Shionogi Seiyaku Kabushiki Kaisha
|
| Vol #:
|
| 1
|
|
|
|
|
| LET
1
|
| U.S. Patent & Trademark Office
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004E-0040
|
| Patent Extension for CYDECTIN, U.S. Patent No. 4,916,154
|
|
|
|
|
| APP 1
|
| American Cyanamid Company
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
|
|
|
| LET
1
|
| U.S. Patent & Trademark Office
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004M-0022
|
| P010059 - Morcher Capsular Tension Ring, Types 14, 14A and 14C, Approved 10/23/03
|
|
|
|
|
| AAV
1
|
| Morcher GMbH
|
| Vol #:
|
| 1
|
|
| |
|
| 2004M-0024
|
| P970020/S040 - ACS MULTI-LINK RX DUET, ACS MULTI-LINK OTW DUET, ACS MULTI-LINK RX TRISTAR, ACS MULTI-LINK OTW TRISTAR, ACS MULTI-LINK RX ULTRA, ACS MULTI-LINK OTW ULTRA, ACS MULTI-LINK RX TETRA, ACS M
|
|
|
|
|
|
|
|
|
|
|
| AAV
1
|
| Guidant Corporation
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004M-0031
|
| PMA P020031, Microsulis Microwave Endometrial Ablation (MEA) System
|
|
|
|
|
| AAV
1
|
| Microsulis Corporation
|
| Vol #:
|
| 1
|
|
